VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE
· Real-Time Price · USD
0.40
-1.04 (-72.22%)
At close: Jul 30, 2025, 3:59 PM
-72.22% (1D)
| Bid | 0.4 |
| Market Cap | 6.65M |
| Revenue (ttm) | 605K |
| Net Income (ttm) | -42.19M |
| EPS (ttm) | -0.98 |
| PE Ratio (ttm) | -0.41 |
| Forward PE | -1.96 |
| Analyst | Hold |
| Ask | 0.43 |
| Volume | 37,035,432 |
| Avg. Volume (20D) | 694,946.1 |
| Open | 0.38 |
| Previous Close | 1.44 |
| Day's Range | 0.36 - 0.44 |
| 52-Week Range | 0.36 - 4.30 |
| Beta | 1.78 |
About VYNE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VYNE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VYNE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
VYNE Therapeutics Inc. is scheduled to release its earnings on
Aug 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
VYNE Therapeutics shares are trading lower after t...
Unlock content with
Pro Subscription
1 month ago
-14.69%
VYNE Therapeutics shares are trading lower after the company provided a program update for VYN202 after receiving a clinical hold from the FDA.
